ADAGRASIB | ADAGRASIB | ATC L01XX77
ANTINEOPLASTIC COVALENT INHIBITOR OF THE RAS GTPASE FAMILY KRAS G12C MUTANT TREATMENT OF METASTATIC NON-SMALL CELL LUNG CANCER (NSCLC) | ORAL | Tmax 6 HOUR VD 942 LITER PPB 98 PERCENT Cl 37 LITER / HOUR HT 23 HOUR SOLUBILITY LESS THAN 0.010 MILLIGRAM PER MILLITER AT PH 7.4 | KRAS G12C | GTPase KRas UNIPROT P01116 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |